VASCONCELLES MICHAEL 4
4 · ImmunoGen, Inc. · Filed Jan 3, 2023
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
VASCONCELLES MICHAEL
EVP R&D & MEDICAL AFFAIRS
Transactions
- Award
Stock Option (Right to Buy)
2022-12-29+960,000→ 960,000 totalExercise: $5.16Exp: 2032-12-29→ Common Stock (960,000 underlying)
Footnotes (1)
- [F1]These options vest over a four-year period, with 25% of the shares vesting on the one-year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant.